CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...
The Brighterside of News on MSN
First human trial of a CRISPR-based treatment significantly lowered cholesterol and triglycerides
A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
Crispr ( CRSP) is said to have attracted takeover interest, according to traders, who cited a Betaville "uncooked' alert that ...
A new study shows that neurons repair CRISPR-Cas9 cuts in unique, highly predictable ways, unlike dividing cells. Researchers ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback